Skip to main content
. 2018 May 17;43(1):149–157. doi: 10.1038/s41366-018-0093-2

Table 1.

Baseline characteristics of the study participants stratified into three groups according to Prevotella-to-Bacteroides (P/B) ratio

0-Prevotella1 (n = 8)  Low P/B group (n = 27) High P/B group (n = 17) P-value
Age (year) 47.9 ± 6.8 43.4 ± 8.7 41.8 ± 11.5 0.33
Gender (% female/male) 100/0 88.9/11.1 76.5/23.5 0.24
Body weight (kg) 82.6 ± 4.6a 84.5 ± 11.4a 95.1 ± 12.0b 0.005
Body mass index (kg/m2) 30.7 ± 1.1a, b 29.7 ± 2.2a 31.9 ± 2.8b 0.017
Body fat (%) 48.7 ± 3.9 44.9 ± 4.1 44.4 ± 5.02 0.069
Fasting glucose (mmol/L) 5.42 ± 0.46 5.55 ± 0.37 5.70 ± 0.55 0.33
Fasting insulin (pmol/L) 63.4 (47.0; 88.1) 38.5 (23.7; 69.3)3 47.8 (28.8; 54.6) 0.17
Prevotella (relative abundance) 0 (0; 0)a 0.0003 (0.0002; 0.001)b 0.155 (0.052; 0.278)c <0.001
Bacteroides (relative abundance) 0.097 (0.032; 0.139)a 0.071 (0.036; 0.111)a 0.012 (0.007; 0.021)b <0.001
Prevotella-to-Bacteroides ratio 0.004 (0.001; 0.012) 11.67 (3.11; 36.03)

Data are presented as mean ± standard deviation, median (interquartile range) or proportions (%) and differences between the three P/B groups were tested using one-way ANOVA with Bonferroni post-hoc tests (some variables transformed before analysis) or Pearson’s chi-squared test. Different alphabets within a row (a, b, c) indicate significant differences (P < 0.05)

P/B Prevotella-to-Bacteroides

10-Prevotella refers to the group of individuals with no detectable Prevotella spp. before intervention.

2n = 16 (missing data for one individual)

3n = 26 (missing data for one individual)